xe-991--anthracenone has been researched along with Epilepsy* in 3 studies
3 other study(ies) available for xe-991--anthracenone and Epilepsy
Article | Year |
---|---|
DV21 decreases excitability of cortical pyramidal neurons and acts in epilepsy.
Epilepsy is one of the most common neurological disorders and the administration of antiepileptic drugs (AEDs) is the most common treatment. Although there are more than 15 AEDs available, a third of epilepsy patients remain refractory to available drugs, so novel effective drugs are needed. Here, we found that DV21, which is a natural triterpenoid compound extracted from plants of the Asclepiadaceae family, significantly decreased the incidence and stages of seizures in three classical drug-induced acute seizure models in C57BL/6 mice. Furthermore, we also found that the antiepileptic effect of DV21 might be partly mediated through reducing the excitability of cortical pyramidal neurons by increasing M current, which are low-threshold non-inactivating voltage-gated potassium currents. Moreover, the application of XE991, an inhibitor of M current, could block most the antiepileptic effect of DV21. Taken together, our results indicated that DV21 might be a novel leading compound for the treatment of epilepsy. Topics: Action Potentials; Animals; Anthracenes; Anticonvulsants; Cerebral Cortex; Disease Models, Animal; Drug Evaluation, Preclinical; Epilepsy; Injections, Intraventricular; Kainic Acid; Mice, Inbred C57BL; Pentylenetetrazole; Pilocarpine; Pyramidal Cells; Severity of Illness Index; Triterpenes; Zebrafish | 2017 |
Raised activity of L-type calcium channels renders neurons prone to form paroxysmal depolarization shifts.
Neuronal L-type voltage-gated calcium channels (LTCCs) are involved in several physiological functions, but increased activity of LTCCs has been linked to pathology. Due to the coupling of LTCC-mediated Ca(2+) influx to Ca(2+)-dependent conductances, such as KCa or non-specific cation channels, LTCCs act as important regulators of neuronal excitability. Augmentation of after-hyperpolarizations may be one mechanism that shows how elevated LTCC activity can lead to neurological malfunctions. However, little is known about other impacts on electrical discharge activity. We used pharmacological up-regulation of LTCCs to address this issue on primary rat hippocampal neurons. Potentiation of LTCCs with Bay K8644 enhanced excitatory postsynaptic potentials to various degrees and eventually resulted in paroxysmal depolarization shifts (PDS). Under conditions of disturbed Ca(2+) homeostasis, PDS were evoked frequently upon LTCC potentiation. Exposing the neurons to oxidative stress using hydrogen peroxide also induced LTCC-dependent PDS. Hence, raising LTCC activity had unidirectional effects on brief electrical signals and increased the likeliness of epileptiform events. However, long-lasting seizure-like activity induced by various pharmacological means was affected by Bay K8644 in a bimodal manner, with increases in one group of neurons and decreases in another group. In each group, isradipine exerted the opposite effect. This suggests that therapeutic reduction in LTCC activity may have little beneficial or even adverse effects on long-lasting abnormal discharge activities. However, our data identify enhanced activity of LTCCs as one precipitating cause of PDS. Because evidence is continuously accumulating that PDS represent important elements in neuropathogenesis, LTCCs may provide valuable targets for neuroprophylactic therapy. Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; 4-Aminopyridine; Animals; Anthracenes; Caffeine; Calcium Channels, L-Type; Calcium Signaling; Cells, Cultured; Dimethyl Sulfoxide; Epilepsy; Excitatory Postsynaptic Potentials; Hippocampus; Hydrogen Peroxide; Isradipine; Magnesium; Neurons; Oxidative Stress; Patch-Clamp Techniques; Rats; Rats, Sprague-Dawley | 2013 |
Molecular identity of the M-channel.
Topics: Anthracenes; Anticonvulsants; Epilepsy; Genes, Dominant; Humans; Neural Conduction; Neurons; Potassium Channels; Receptors, Muscarinic | 2000 |